Biomarker analysis performed in serum of patients with WNT1 osteoporosis revealed increased levels of fibroblast growth factor 23 [88]—a bone-derived hormone—, and a disease-specific miRNA signature [93]. The gene discussed is WNT1; the disease is osteoporosis.